Miniaturization and Automation of Tissue Chip Systems (MATChS) (U43/U44 Clinical Trial Not Allowed)
Department of Health and Human Services ▸ National Institutes of Health ▸
Description
This grant opportunity supports small businesses in developing MATChS through a cooperative agreement. Projects should focus on creating tools and technologies for high-throughput automated processes that include on-line sensing, rapid data acquisition, and analysis to minimize manual work. Successful projects will lead to more widely available miniaturized automated tissue chip platforms that can be used in drug development and various biomedical research applications.
This Notice of Funding Opportunity (NOFO) invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) Phase I, Phase II, Fast-Track and Direct to Phase II grant applications. The funding opportunity will utilize a U43/U44 cooperative agreemen…
Source
Grant ID
RFA-TR-23-017
Funding Source
Department of Health and Human Services ▸ National Institutes of Health ▸
Key Dates
Opportunity Released
November 21, 2023
Open for Submission
November 21, 2023
Submission Deadline
February 23, 2026
Application Window Closes
February 23, 2026
Eligibility
The following categories of applicants are invited to apply:
- For-Profit Organizations: United States Small Business Concerns (SBCs) meeting SBA SBIR eligibility (organized for profit; place of business in the U.S.; operates primarily in the U.S. or makes a significant contribution to the U.S. economy; ≤500 employees including affiliates)
- For-Profit Organizations: Joint ventures that qualify as SBCs under SBA rules (SBIR-eligible; with <50% participation by foreign business entities in the joint venture)
- For-Profit Organizations: SBCs majority-owned by multiple venture capital operating companies, hedge funds, or private equity firms (SBIR-only; not eligible for STTR)
Awards & Funding
Award Floor
$350,000
Funding Amount
Discretionary
Similar opportunities
- Miniaturization and Automation of Tissue Chip Systems (MATChS) (UT1/UT2 - Clinical Trial Not Allowed)
- Innovative Research in Cancer Nanotechnology (IRCN)
- Biosensing
- Notice of Funding Opportunity (NOFO) for Development of Biomedical Technologies
- Aging Mammalian Tissues In Vitro (R21 Clinical Trial Not Allowed)